Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/238.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) > Corynebacterium (e.g., corynebacterium diphtheriae, etc.)
Description: Subject matter wherein the toxin or toxoid originates from a bacterium of the genus Corynebacterium.

Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
8642044 Prevention and treatment of amyloidogenic disease Feb. 4, 2014
8623380 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids Jan. 7, 2014
8551451 Combination vaccine with acellular pertussis Oct. 8, 2013
8409584 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins Apr. 2, 2013
8048985 Diphtheria toxin variant Nov. 1, 2011
8034348 Prevention and treatment of amyloidogenic disease Oct. 11, 2011
8007818 Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines Aug. 30, 2011
7674892 Hsp70 from Arthrobacter Mar. 9, 2010
7585942 Diphtheria toxin variant Sep. 8, 2009
7399472 Vaccines Jul. 15, 2008
7384652 Complexed-acidic-phospholipid-collagen composites for bone induction Jun. 10, 2008
7279169 Mucosal DTPa vaccines Oct. 9, 2007
7169392 Neisseria meningitidis serogroup B glycoconjugates and methods of producing the same Jan. 30, 2007
7098303 Conserved motif of hepatitis C virus E2/NS1 region Aug. 29, 2006
6866847 Method of delivering a protein to poultry Mar. 15, 2005
6846484 DTAT fusion toxin Jan. 25, 2005
6841160 Meningococcal vaccines formulated with interleukin-12 Jan. 11, 2005
6746677 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation Jun. 8, 2004
6737511 Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis May. 18, 2004
6506388 Immunomodulator, immunomodulator food Jan. 14, 2003
6455673 Multi-mutant diphtheria toxin vaccines Sep. 24, 2002
6444446 Calcium binding proteolipid compositions and methods Sep. 3, 2002
5897867 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Apr. 27, 1999
5895655 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Apr. 20, 1999
5885587 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Mar. 23, 1999
5885586 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens Mar. 23, 1999
5866128 Method for the treatment and prevention of gastric and duodenal ulcer Feb. 2, 1999
5861162 Multivalent inocula for lessening incidence of liver abscesses in cattle Jan. 19, 1999
5843462 Diphtheria toxin epitopes Dec. 1, 1998
5830478 Method for delivering functional domains of diphtheria toxin to a cellular target Nov. 3, 1998
5785970 Method of the treatment of gastrointestinal disorders with immunogenic compositions against gastrin Jul. 28, 1998
5725857 Immunotoxin with in vivo T cell suppressant activity and methods of use Mar. 10, 1998
5601827 Diphtheria toxin vaccines Feb. 11, 1997
5529777 Hydrogel microencapsulated vaccines Jun. 25, 1996
5139776 Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine Aug. 18, 1992
5110794 Method of immunization with partially cationized substances and said partially cationized substances May. 5, 1992
5097020 Immunogenic conjugates Mar. 17, 1992
5019383 Fatty acid carriers for synthetic peptides May. 28, 1991
4902506 Immunogenic conjugates Feb. 20, 1990
4762713 Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers Aug. 9, 1988
4711779 Glycoproteinic conjugates having trivalent immunogenic activity Dec. 8, 1987
4705686 Process for the preparation of acellular Bordetalla pertussis vaccine Nov. 10, 1987
4673574 Immunogenic conjugates Jun. 16, 1987
4619828 Polysaccharide exotoxoid conjugate vaccines Oct. 28, 1986
4578270 Process for the preparation of lyophilized, adsorbed polyvalent vaccines Mar. 25, 1986
4478823 Immunological preparations containing purified MHC antigens bonded to other antigens Oct. 23, 1984
4455142 Method of coadministering an antigen and an immunopotentiator Jun. 19, 1984
4428931 Bacterial toxoids and gram-negative immune globulin therefrom Jan. 31, 1984
4400376 Immunological preparations Aug. 23, 1983
4372883 Process for the production of vaccine Feb. 8, 1983

1 2

  Recently Added Patents
Point-in-time copies in a cascade using maps and fdisks
Nuclear fuel assembly bottom nozzle
Compositions and methods using microspheres and non-ionic contrast agents
Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
System and method of automatic piloting for in-flight refuelling of aircraft, and aircraft comprising said system
Triazine ring-containing polymer and film-forming composition comprising same
  Randomly Featured Patents
Gaming device and method having a first interactive game which determines a function of a second wagering game
Method for determining the behavior of shafts of a multi-shaft machine which are jointly movable to move a tool or a tool receptacle
Neovascular-targeted immunoconjugates
System and method for providing secure access to password-protected resources
Snowmobile ski
Antibodies specific for the protofibril form of beta-amyloid protein
Debris sensor for cleaning apparatus
Electrical connector device with a number of terminals
Procedure for in-situ determination of thermal gradients at the crystal growth front
Switching device with a vacuum interrupter chamber